Gadolinium Side Effects
The Food and Drug Administration (FDA) has asked the manufacturers of gadolinium-based contrast agents to include a new boxed warning that alerts consumers of the potential development of NFS / NFD (Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermopathy).
Those facing a significant risk of developing NSF / NFD include those suffering from kidney malfunction or advanced renal failure, liver transplantation patients (preoperative & postoperative), and people suffering from chronic liver disease. Any such “at-risk” people are strongly advised to avoid gadolinium-based products to prevent NSF / NFD development. Symptoms of NSF / NFD may begin to develop shortly after injection of a gadolinium contrast agent, but may also take up to 18 months to fully develop.
What is NSF / NFD?
NSF / NFD is a disease of the skin and connective tissue. NSF / NFD sufferers may experience significant thickening of the skin to the extent that joint mobility becomes limited. Fibrotic scarring may also spread from its common areas to other parts of the body including the diaphragm, lungs, lower abdomen and muscles of the thigh. Although NSF / NFD was not described in medical literature until 2000, the first case of the skin disease was documented in 1997.
Gadolinium Contrast Agent Injuries
Gadolinium contrast agents are used to enhance the quality of an MRI scan. Although gadolinium-based agents have proven to be extremely useful when used in conjunction with MRI’s, they are also capable of eliciting some serious and potentially fatal side effects. According to recent FDA reports, a single injection of gadolinium could potentially result in the development of NSF / NFD.
The most commonly used gadolinium contrast agent is OmniScan (gadodiamide); however, there are five different types that have been approved for use by the FDA:
- OmniScan (gadodiamide)
- OptiMark (gadoversetamide)
- Prohance (gadoteridol)
- Magnevist (gadopentate dimeglumine)
- MultiHance (gadobenate dimeglumine)
Gadolinium Side Effect Lawsuits
Drug manufacturers are responsible for ensuring the safety and efficacy of their products before marketing them for public consumption. Failure to do so is considered negligent and grounds for personal injury litigation. The Pensacola personal injury attorneys of Aylstock, Witkin Kreis & Overholtz handle national litigation across the United States for victims injured by defective pharmaceuticals and medical devices. They have successfully represented and obtained substantial compensation for a number of patients who have been harmed by defective drugs. Contact AWKO law today at (844) 794-7402 to get more information about your rights as a Gadolinium injury victim.